• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型隐球菌A血清型菌株纯化及放射性碘化荚膜多糖与无荚膜突变体的结合

Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.

作者信息

Small J M, Mitchell T G

出版信息

Infect Immun. 1986 Dec;54(3):742-50. doi: 10.1128/iai.54.3.742-750.1986.

DOI:10.1128/iai.54.3.742-750.1986
PMID:3536747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC260232/
Abstract

Strains 6, 15, 98, 110, and 145 of Cryptococcus neoformans serotype A vary in capsule size, animal virulence, and susceptibility to in vitro phagocytosis. The isolated capsular polysaccharides (CPSs) differ in monosaccharide composition ratios and molecular size, as determined by gel filtration. The purpose of this investigation was to characterize the binding of CPSs to capsule-free mutants of C. neoformans and to examine CPSs from these strains for differences in their ability to bind, to determine whether such differences might explain the variation in the pathobiology of these strains. CPSs were partially periodate oxidized, tyraminated, iodinated with 125I, and used in binding studies with two capsule-free mutants of C. neoformans, strain 602 and Cap59. Binding was specific for yeast species and for polysaccharide and was saturable, which is consistent with a receptor-mediated mechanism of attachment. Binding occurred rapidly and was only slowly reversible. Binding was also independent of pH from pH 5.5 to 8, of cation concentrations, and of competition by sugars up to 1.0 M concentrations. Only a portion of CPS was capable of binding, and strains varied in the extent to which their CPS bound. CPS-15-IV (peak IV was the major polysaccharide peak on DEAE-cellulose chromatography of CPS from strain 15) had the highest proportion of binding (40%), followed by CPS from strains 98, 6, 145, 110, and 15-III (peak III was an earlier eluting fraction of CPS from strain 15). The CPSs differed similarly in their ability to competitively inhibit binding. Treatment of CPS, but not yeast cells, with proteinase XIV abolished binding without altering the CPS gross structure. Treatment of yeast cells with proteases, heat, or formaldehyde did not alter binding, and both strain 602 and Cap59 bound CPS similarly. Binding to encapsulated yeast cells was minimal.

摘要

新型隐球菌A血清型的6、15、98、110和145菌株在荚膜大小、动物毒力以及对体外吞噬作用的敏感性方面存在差异。通过凝胶过滤测定,分离出的荚膜多糖(CPS)在单糖组成比例和分子大小上有所不同。本研究的目的是表征CPS与新型隐球菌无荚膜突变体的结合情况,并检测这些菌株的CPS在结合能力上的差异,以确定这种差异是否可以解释这些菌株在病理生物学上的变化。CPS经部分高碘酸盐氧化、酪胺化、用125I碘化后,用于与新型隐球菌的两个无荚膜突变体602菌株和Cap59进行结合研究。结合对酵母种类和多糖具有特异性,且具有饱和性,这与受体介导的附着机制一致。结合迅速发生且仅缓慢可逆。结合也与pH值在5.5至8之间、阳离子浓度以及高达1.0 M浓度的糖的竞争无关。只有一部分CPS能够结合,且不同菌株的CPS结合程度不同。CPS - 15 - IV(峰IV是菌株15的CPS在DEAE - 纤维素色谱上的主要多糖峰)的结合比例最高(40%),其次是菌株98、6、145、110的CPS以及15 - III(峰III是菌株15的CPS较早洗脱的部分)。CPS在竞争抑制结合的能力方面也有类似差异。用蛋白酶XIV处理CPS而非酵母细胞可消除结合,且不改变CPS的总体结构。用蛋白酶、加热或甲醛处理酵母细胞不会改变结合,并且602菌株和Cap59对CPS的结合情况相似。与有荚膜酵母细胞的结合极少。

相似文献

1
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.新型隐球菌A血清型菌株纯化及放射性碘化荚膜多糖与无荚膜突变体的结合
Infect Immun. 1986 Dec;54(3):742-50. doi: 10.1128/iai.54.3.742-750.1986.
2
Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.新型隐球菌A血清型荚膜多糖抗吞噬活性的菌株变异
Infect Immun. 1989 Dec;57(12):3751-6. doi: 10.1128/iai.57.12.3751-3756.1989.
3
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.新型隐球菌A血清型荚膜多糖的组成和分子大小的菌株变异
Infect Immun. 1986 Dec;54(3):735-41. doi: 10.1128/iai.54.3.735-741.1986.
4
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.隐球菌多糖与新型隐球菌的结合。
Infect Immun. 1984 Mar;43(3):879-86. doi: 10.1128/iai.43.3.879-886.1984.
5
Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.新型隐球菌新生变种血清型A与浅白隐球菌浅白变种荚膜多糖的血清学及化学特性比较
Microbiol Immunol. 1991;35(2):125-38. doi: 10.1111/j.1348-0421.1991.tb01540.x.
6
Anti-chemotactic activity of capsular polysaccharide of Cryptococcus neoformans in vitro.新型隐球菌荚膜多糖的体外抗趋化活性
Microbiol Immunol. 1997;41(9):657-64. doi: 10.1111/j.1348-0421.1997.tb01908.x.
7
Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.新型隐球菌的非包膜变种。II. 隐球菌多糖的表面受体及其在多糖抑制吞噬作用中的作用。
Infect Immun. 1977 Apr;16(1):99-106. doi: 10.1128/iai.16.1.99-106.1977.
8
Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis.新型隐球菌荚膜多糖分子大小对吞噬作用的影响。
Microbiol Immunol. 1994;38(11):851-6. doi: 10.1111/j.1348-0421.1994.tb02137.x.
9
Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture.新型隐球菌荚膜再生实验揭示了增大和结构的动态变化。
J Biol Chem. 2022 Apr;298(4):101769. doi: 10.1016/j.jbc.2022.101769. Epub 2022 Feb 24.
10
Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan.新型隐球菌CAP59(或Cap59p)参与荚膜葡糖醛酸木聚糖的细胞外运输。
Eukaryot Cell. 2004 Apr;3(2):385-92. doi: 10.1128/EC.3.2.385-392.2004.

引用本文的文献

1
The Cryptococcus neoformans capsule: a sword and a shield.新生隐球菌荚膜:一把双刃剑。
Clin Microbiol Rev. 2012 Jul;25(3):387-408. doi: 10.1128/CMR.00001-12.
2
Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.致病和非致病隐球菌属的胶囊在结构和抵御吞噬细胞的能力方面表现出显著差异。
PLoS One. 2012;7(1):e29561. doi: 10.1371/journal.pone.0029561. Epub 2012 Jan 12.
3
The outcome of phagocytic cell division with infectious cargo depends on single phagosome formation.携带感染性物质的吞噬细胞分裂结果取决于单个吞噬体的形成。
PLoS One. 2008 Sep 16;3(9):e3219. doi: 10.1371/journal.pone.0003219.
4
A yeast under cover: the capsule of Cryptococcus neoformans.隐藏在酵母之下:新型隐球菌的荚膜
Eukaryot Cell. 2003 Aug;2(4):655-63. doi: 10.1128/EC.2.4.655-663.2003.
5
Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages.新型隐球菌与变形虫的相互作用为其在巨噬细胞中的毒力和细胞内致病策略提供了一种解释。
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15245-50. doi: 10.1073/pnas.261418798. Epub 2001 Dec 11.
6
Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.新型隐球菌被葡糖醛酸木聚糖甘露聚糖包裹会抑制单核细胞的抗原呈递能力。
Infect Immun. 1998 Feb;66(2):664-9. doi: 10.1128/IAI.66.2.664-669.1998.
7
Tumor necrosis factor-inducing activities of Cryptococcus neoformans components.新型隐球菌成分的肿瘤坏死因子诱导活性。
Infect Immun. 1996 Dec;64(12):5199-204. doi: 10.1128/iai.64.12.5199-5204.1996.
8
Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.新型隐球菌的荚膜多糖可诱导人中性粒细胞释放促炎细胞因子。
Infect Immun. 1996 Aug;64(8):2897-903. doi: 10.1128/iai.64.8.2897-2903.1996.
9
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.艾滋病时代的隐球菌病——新型隐球菌发现100年后
Clin Microbiol Rev. 1995 Oct;8(4):515-48. doi: 10.1128/CMR.8.4.515.
10
Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.多糖荚膜及其制备方法对新型隐球菌刺激下人类淋巴细胞增殖的影响。
Infect Immun. 1993 Feb;61(2):464-9. doi: 10.1128/iai.61.2.464-469.1993.

本文引用的文献

1
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.新型隐球菌非包被变异株 I. 毒力研究及可溶性多糖的特性。
Infect Immun. 1971 Feb;3(2):287-94. doi: 10.1128/iai.3.2.287-294.1971.
2
Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases.隐球菌病的组织变化与组织诊断;26例研究
Am J Clin Pathol. 1955 Jan;25(1):14-24. doi: 10.1093/ajcp/25.1.14.
3
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.高比放射性碘-131标记人生长激素的制备
Biochem J. 1963 Oct;89(1):114-23. doi: 10.1042/bj0890114.
4
A radioimmunoassay for antibody to pneumococcal polysaccharides.一种针对肺炎球菌多糖抗体的放射免疫测定法。
J Immunol Methods. 1982;49(1):83-8. doi: 10.1016/0022-1759(82)90368-4.
5
Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.新型隐球菌荚膜突变体的遗传与表型特征分析
J Bacteriol. 1982 Jun;150(3):1292-6. doi: 10.1128/jb.150.3.1292-1296.1982.
6
Altered responsiveness of murine lymphoid cells treated with cryptococcal capsular polysaccharide.
Proc Soc Exp Biol Med. 1982 Apr;169(4):427-31. doi: 10.3181/00379727-169-41370.
7
Selective diminution of the binding of mannose by murine macrophages in the late stages of activation.在激活后期,小鼠巨噬细胞对甘露糖结合的选择性减少。
J Biol Chem. 1982 May 10;257(9):5129-35.
8
Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype A.来自新型隐球菌血清型A亲本菌株和可能的突变菌株的荚膜多糖。
Carbohydr Res. 1981 Sep 16;95(2):237-48. doi: 10.1016/s0008-6215(00)85580-9.
9
Lipid on capsular polysaccharides of gram-negative bacteria.革兰氏阴性菌荚膜多糖上的脂质。
J Biol Chem. 1981 Sep 10;256(17):8915-21.
10
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.隐球菌多糖的表面电荷与吞噬作用抑制之间存在伴随但非因果的关联。
Infect Immun. 1980 Aug;29(2):295-300. doi: 10.1128/iai.29.2.295-300.1980.